US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VictoryShares US 500 Enhanced Volatility Wtd ETF

72.87

-0.9095-1.23%

Post-market: 72.83-0.0415-0.06%16:10 EDT

Volume:4.27K

Turnover:313.35K

Market Cap:389.86M

PE:364.36

High:73.63

Open:73.44

Low:72.83

Close:73.78

52wk High:78.74

52wk Low:60.03

Shares:5.35M

Float Shares:5.35M

Volume Ratio:0.62

T/O Rate:0.08%

Dividend:0.99

Dividend Rate:1.36%

EPS(TTM):0.2000

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Codere Online to Participate in Upcoming Investor Conferences

Press Release: Max Stock Limited Reports Third Quarter 2025 Financial Results

Press Release: James M. O'Brien Appointed Chief Financial Officer at Mesoblast

Director/PDMR Shareholding

On Holding Raises Full-Year Guidance, Shares Surge 21.5%

Lifecore Biomedical to Participate in Upcoming Investor Conferences

Press Release: Edgewise Therapeutics Announces Appointment of Michael Nofi as Chief Financial Officer, and the Retirement of Current CFO, R. Michael Carruthers

Danske Bank A/S, transactions by persons discharging managerial responsibilities

Press Release: The Adecco Group announces new chief financial officer

Press Release: The Adecco Group announces new chief financial officer

French Satellite Operator Eutelsat Appoints Imerys Executive as Next CFO

Rapid7 Announces Third Quarter 2025 Financial Results

Press Release: Visionary Holdings Inc. Announces Successful Leadership Transition: Elite Governance Team Leads the Way, Standardized Structure Empowers High-Quality Development

K Wave Media Appoints Yong Fang as Chief Financial Officer

Press Release: Bank of the James Announces CFO--CIO Transition and Appointment of New Chief Financial Officer

Fiserv Cuts Annual Profit Forecast, Shares Plunge 27%

Lifecore Biomedical Selected as New Commercial Manufacturing Partner by Leading Global Pharmaceutical Company

Lifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. Market

Elon Musk Loses Another Top Executive As X's Ad Chief Reportedly Quits

Benzinga_recent_news

Avacta Therapeutics Presents Compelling Phase 1a Data for Faridoxorubicin and the pre|CISION® Platform at the European Society of Medical Oncology Annual Congress

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CFO/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CFO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CFO\",,,,,undefined,":{"symbol":"CFO","market":"US","secType":"STK","nameCN":"VictoryShares US 500 Enhanced Volatility Wtd ETF","latestPrice":72.8715,"timestamp":1774641600000,"preClose":73.781,"halted":0,"volume":4271,"hourTrading":{"tag":"盘后","latestPrice":72.83,"preClose":72.8715,"latestTime":"16:10 EDT","volume":7,"amount":509.743,"timestamp":1774642204312,"change":-0.0415,"changeRate":-0.000569,"amplitude":0},"delay":0,"changeRate":-0.012327021861997104,"floatShares":5350000,"shares":5350000,"eps":0.2,"marketStatus":"Market Closed","change":-0.9095,"latestTime":"03-27 16:00:00 EDT","open":73.44,"high":73.63,"low":72.83,"amount":313353.3541,"amplitude":0.010843,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0.2,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":73.781,"sharesOutstanding":5350000,"nav":72.88741,"aum":389947590,"dividendRate":0.01358,"bidAskSpread":0.0005,"postHourTrading":{"tag":"盘后","latestPrice":72.83,"preClose":72.8715,"latestTime":"16:10 EDT","volume":7,"amount":509.743,"timestamp":1774642204312,"change":-0.0415,"changeRate":-0.000569,"amplitude":0},"volumeRatio":0.6152937288223022,"impliedVol":0.0807,"impliedVolPercentile":0.7769},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CFO\",,,,,undefined,":{"symbol":"CFO","floatShares":5350000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.6152937288223022,"shares":5350000,"dividePrice":0.9896,"high":73.63,"amplitude":0.010843,"preClose":73.781,"low":72.83,"week52Low":60.03,"pbRate":"--","week52High":78.735,"institutionHeld":0,"latestPrice":72.8715,"eps":0.2,"divideRate":0.01358,"volume":4271,"delay":0,"ttmEps":0.2,"open":73.44,"prevYearClose":73.8438,"prevWeekClose":73.1465,"prevMonthClose":78.4089,"prevQuarterClose":73.8438,"fiveDayClose":73.1465,"twentyDayClose":78.4089,"sixtyDayClose":74.4231},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CFO\",params:#limit:5,,,undefined,":[{"date":"2026-03-10","symbol":"CFO","amount":0.12146,"announcedDate":"2026-03-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-10","defaultRemindTime":1773149400000,"name":"VictoryShares US 500 Enhanced Volatility Wtd ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-11","payableDate":"2026-03-10","currency":"USD","dateTimestamp":1773115200000,"payDate":"2026-03-11"},{"date":"2026-02-09","symbol":"CFO","amount":0.041108,"announcedDate":"2026-02-06","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-02-09","defaultRemindTime":1770647400000,"name":"VictoryShares US 500 Enhanced Volatility Wtd ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-02-10","payableDate":"2026-02-09","currency":"USD","dateTimestamp":1770613200000,"payDate":"2026-02-10"},{"date":"2026-01-08","symbol":"CFO","amount":0.111805,"announcedDate":"2026-01-07","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-01-08","defaultRemindTime":1767882600000,"name":"VictoryShares US 500 Enhanced Volatility Wtd ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-09","payableDate":"2026-01-08","currency":"USD","dateTimestamp":1767848400000,"payDate":"2026-01-09"},{"date":"2025-12-11","symbol":"CFO","amount":0.110156,"announcedDate":"2025-12-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-11","defaultRemindTime":1765463400000,"name":"VictoryShares US 500 Enhanced Volatility Wtd ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-12","payableDate":"2025-12-11","currency":"USD","dateTimestamp":1765429200000,"payDate":"2025-12-12"},{"date":"2025-11-07","symbol":"CFO","amount":0.035223,"announcedDate":"2025-11-06","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-11-07","defaultRemindTime":1762525800000,"name":"VictoryShares US 500 Enhanced Volatility Wtd ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-11-10","payableDate":"2025-11-07","currency":"USD","dateTimestamp":1762491600000,"payDate":"2025-11-10"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CFO\",market:\"US\",,,undefined,":[{"executeDate":"2016-06-14","recordDate":"2016-06-16","paymentDate":"2016-06-17","value":0.1457861,"currency":"USD"},{"executeDate":"2016-09-07","recordDate":"2016-09-09","paymentDate":"2016-09-12","value":0.1089324,"currency":"USD"},{"executeDate":"2016-11-15","recordDate":"2016-11-17","paymentDate":"2016-11-18","value":0.086566,"currency":"USD"},{"executeDate":"2016-12-13","recordDate":"2016-12-15","paymentDate":"2016-12-16","value":0.0834409,"currency":"USD"},{"executeDate":"2017-01-17","recordDate":"2017-01-19","paymentDate":"2017-01-20","value":0.020249,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CFO\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CFO\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2584153994","title":"Codere Online to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2584153994","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584153994?lang=en_us&edition=fundamental","pubTime":"2025-11-20 23:22","pubTimestamp":1763652120,"startTime":"0","endTime":"0","summary":"Madrid, Spain and Tel Aviv, Israel, November 20, 2025 (GLOBE NEWSWIRE) – Codere Online Luxembourg, S.A. (Nasdaq: CDRO / CDROW) (the “Company” or “Codere Online”) a leading online gaming operator in Sp","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/20/3192130/0/en/Codere-Online-to-Participate-in-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CFO"],"gpt_icon":0},{"id":"2584799246","title":"Press Release: Max Stock Limited Reports Third Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2584799246","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584799246?lang=en_us&edition=fundamental","pubTime":"2025-11-19 13:30","pubTimestamp":1763530200,"startTime":"0","endTime":"0","summary":"Third Quarter Revenue Increased 7.0% to ILS 399.1 million; Comparable Store Sales Increased 5.0%; Gross Margin Increased 300 Basis Points; Adjusted EBITDA Increased 22.6%; GAAP Net income  Increased 31.1% to ILS 44.9 million. CAESAREA, Israel, Nov. 19, 2025 /PRNewswire/ -- Max Stock Limited   today reported financial results for the third quarter and nine months ended September 30, 2025.-- Revenue increased 7.0% to ILS 399.1 million.-- Adjusted EPS1  increased 30.3% to ILS 0.29.\"We delivered strong third quarter results that included an acceleration of our comparable store sales growth rate, 300-basis point gross margin expansion and a strong double digit growth in our net income,\" said Ori Max, Founder and Chief Executive Officer. \"We are pleased with the continued strength of our recent performance, on top of strong multi-year comparison, which underscores the success of our business model and our recent actions to enhance the efficiency of our supply chain.  Looking ahead, we believ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CFO","BK4157","LINK","BK4078","GPRO"],"gpt_icon":0},{"id":"2584737614","title":"Press Release: James M. O'Brien Appointed Chief Financial Officer at Mesoblast","url":"https://stock-news.laohu8.com/highlight/detail?id=2584737614","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584737614?lang=en_us&edition=fundamental","pubTime":"2025-11-17 14:52","pubTimestamp":1763362320,"startTime":"0","endTime":"0","summary":"NEW YORK, Nov. 17, 2025  -- Mesoblast Limited , global leader in allogeneic cellular medicines for inflammatory diseases, today announced that in connection with the Company's transition to a fully integrated commercial organization it has appointed James M. O'Brien as its US-based Chief Financial Officer . Jim has extensive experience in all aspects of financial management and planning having spent the majority of his career with multi-national public and private companies in the life sciences, biotechnology, and pharmaceutical industries.Mesoblast  is a world leader in developing allogeneic  cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The therapies from the Company's proprietary mesenchymal lineage cell therapy technology platform respond to severe inflammation by releasing anti-inflammatory factors that counter and modulate multiple effector arms of the immune system, resulting in significant red","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","MESO","BK4139","BK4006","BK4575","R","BK4232","MSB","BK4150","MSB.AU","BK7067","BK7501","MSC","BMS","CFO","BK4022"],"gpt_icon":0},{"id":"2583036875","title":"Director/PDMR Shareholding","url":"https://stock-news.laohu8.com/highlight/detail?id=2583036875","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583036875?lang=en_us&edition=fundamental","pubTime":"2025-11-14 19:44","pubTimestamp":1763120640,"startTime":"0","endTime":"0","summary":"NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM Admiral Group Plc (Admiral or Company) PDMR/PCA Shareholding Admiral has been n","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/14/3188169/0/en/Director-PDMR-Shareholding.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CFO"],"gpt_icon":0},{"id":"1145113585","title":"On Holding Raises Full-Year Guidance, Shares Surge 21.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1145113585","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145113585?lang=en_us&edition=fundamental","pubTime":"2025-11-12 23:43","pubTimestamp":1762962182,"startTime":"0","endTime":"0","summary":"On Holding (NYSE: ONON) shares soared in early Wednesday trading after the company reported better-than-expected Q3 results and raised its full-year outlook. CEO Martin Hoffmann highlighted strong...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"a9a030cab83801771b28786b1a7c13c8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4567","BK4146","CFO","BK4561","DECK","BK4588","LU1303367103.USD","IE00BFXG0V08.USD","LU0128525929.USD","LU0786609619.USD","BK4534","IE00BYQQ9H92.USD","LU1267930573.SGD","LU0266013472.USD","LU2098885051.SGD","NKE","BK4558","BK4533","BK4585","LU0310800379.SGD","LU0823411888.USD","BK4566","LU0708994859.HKD","BK4581","LU0029864427.USD"],"gpt_icon":1},{"id":"2582390231","title":"Lifecore Biomedical to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2582390231","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582390231?lang=en_us&edition=fundamental","pubTime":"2025-11-12 05:05","pubTimestamp":1762895100,"startTime":"0","endTime":"0","summary":"Vida Strategic Partners. Stephanie Diaz (Investors). 415-675-7401. sdiaz@vidasp.com. Tim Brons (Media). 415-675-7402. tbrons@vidasp.com. Ryan D. Lake (CFO). 952-368-6244. ryan.lake@lifecore.com","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/11/3185766/23089/en/Lifecore-Biomedical-to-Participate-in-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CFO","BK4212","CDMO","BK4121","BK4139","LFCR"],"gpt_icon":0},{"id":"2582879155","title":"Press Release: Edgewise Therapeutics Announces Appointment of Michael Nofi as Chief Financial Officer, and the Retirement of Current CFO, R. Michael Carruthers","url":"https://stock-news.laohu8.com/highlight/detail?id=2582879155","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582879155?lang=en_us&edition=fundamental","pubTime":"2025-11-10 21:00","pubTimestamp":1762779600,"startTime":"0","endTime":"0","summary":"BOULDER, Colo., Nov. 10, 2025 /PRNewswire/ -- Edgewise Therapeutics, Inc., , a leading muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions, today announced the appointment of Michael Nofi, as Chief Financial Officer , effective November 10, 2025. Mr. Nofi joins Edgewise after serving as Chief Accounting Officer  at SpringWorks Therapeutics, Inc. Mr. Nofi will succeed Edgewise CFO, R. Michael Carruthers, who is retiring.Edgewise Therapeutics is a leading muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The Company's deep expertise in muscle physiology is driving a new generation of novel therapeutics. Sevasemten is an orally administered first-in-class fast skeletal myosin inhibitor in late-stage clinical trials in Becker and Duchenne muscular dystrophies. EDG-7500 is a novel cardiac sarcomere modulator for the treatment of hypertrophi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CFO","BK4539","EWTX"],"gpt_icon":0},{"id":"2581988900","title":"Danske Bank A/S, transactions by persons discharging managerial responsibilities","url":"https://stock-news.laohu8.com/highlight/detail?id=2581988900","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581988900?lang=en_us&edition=fundamental","pubTime":"2025-11-07 22:32","pubTimestamp":1762525920,"startTime":"0","endTime":"0","summary":"7 November 2025 Notification no. 77/2025 Transactions made by persons obliged to report transactions to the Danish FSA and Nasdaq Copenhagen, cf. the EU Market Abuse Regulation.  Cecile Hillary, the Chief Financial Officer  of Danske Bank A/S, has sold shares to cover tax obligations related to shares granted as part of her sign-on fee.For further details, please find the attached template for notifications and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them. Contact: Claus Ingar Jensen, Head of Group Investor Relations, tel. +45 25 42 43 70","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/07/3183751/0/en/Danske-Bank-A-S-transactions-by-persons-discharging-managerial-responsibilities.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CFO"],"gpt_icon":0},{"id":"2581034789","title":"Press Release: The Adecco Group announces new chief financial officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2581034789","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581034789?lang=en_us&edition=fundamental","pubTime":"2025-11-06 13:45","pubTimestamp":1762407900,"startTime":"0","endTime":"0","summary":"AD HOC ANNOUNCEMENT pursuant to Art. 53 Listing Rules of SIX Swiss Exchange. ZURICH, Nov. 6, 2025 /PRNewswire/ -- The Adecco Group , today announces the appointment of Valentina Ficaio as chief financial officer  and member of the executive committee, from January 1, 2026. She will succeed Coram Williams who has decided to step down and will assume the role of CFO for a company in the automotive sector in Germany in the New Year. Coram joined the Adecco Group in 2020.Valentina, who is Italian, joined the Adecco Group as CFO Iberia in 2019 and then became regional CFO for Southern and Eastern Europe, Middle East and Northern Africa. She is now group senior vice president finance, leading financial planning, controllership and strategy. Prior to joining the Adecco Group, Valentina held CFO roles in the automotive industry and automotive financing and banking. She has a business and managerial economics degree from Luiss Guido Carli University, Rome.Please view full press release and biog","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CFO"],"gpt_icon":0},{"id":"2581034786","title":"Press Release: The Adecco Group announces new chief financial officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2581034786","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581034786?lang=en_us&edition=fundamental","pubTime":"2025-11-06 13:45","pubTimestamp":1762407900,"startTime":"0","endTime":"0","summary":"AD HOC ANNOUNCEMENT pursuant to Art. 53 Listing Rules of SIX Swiss Exchange. ZURICH, Nov. 6, 2025 /CNW/ -- The Adecco Group , today announces the appointment of Valentina Ficaio as chief financial officer  and member of the executive committee, from January 1, 2026. She will succeed Coram Williams who has decided to step down and will assume the role of CFO for a company in the automotive sector in Germany in the New Year. Coram joined the Adecco Group in 2020.Valentina, who is Italian, joined the Adecco Group as CFO Iberia in 2019 and then became regional CFO for Southern and Eastern Europe, Middle East and Northern Africa. She is now group senior vice president finance, leading financial planning, controllership and strategy. Prior to joining the Adecco Group, Valentina held CFO roles in the automotive industry and automotive financing and banking. She has a business and managerial economics degree from Luiss Guido Carli University, Rome.Please view full press release and biography h","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CFO"],"gpt_icon":0},{"id":"1133440699","title":"French Satellite Operator Eutelsat Appoints Imerys Executive as Next CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=1133440699","media":"Deep News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133440699?lang=en_us&edition=fundamental","pubTime":"2025-11-05 17:00","pubTimestamp":1762333218,"startTime":"0","endTime":"0","summary":"French satellite operator Eutelsat announced on Wednesday that it has appointed Sébastien Rouge as its new Chief Financial Officer (CFO).   Rouge currently serves as the financial head of mineral...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CFO"],"gpt_icon":0},{"id":"2581696417","title":"Rapid7 Announces Third Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2581696417","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581696417?lang=en_us&edition=fundamental","pubTime":"2025-11-05 05:01","pubTimestamp":1762290060,"startTime":"0","endTime":"0","summary":"Annualized recurring revenue (“ARR”) of $838 million, an increase of 2% year-over-yearTotal revenue of $218 million, up 2% year-over-year; Product subscriptions revenue of $210 million, up 2% year-ove","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/04/3180808/36514/en/Rapid7-Announces-Third-Quarter-2025-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CFO","RPD","BK4097","LU1878469433.USD"],"gpt_icon":0},{"id":"2580758164","title":"Press Release: Visionary Holdings Inc. Announces Successful Leadership Transition: Elite Governance Team Leads the Way, Standardized Structure Empowers High-Quality Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2580758164","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580758164?lang=en_us&edition=fundamental","pubTime":"2025-11-04 22:30","pubTimestamp":1762266600,"startTime":"0","endTime":"0","summary":"TORONTO, Nov. 4, 2025 /PRNewswire/ -- At 10:00 a.m.  on November 3, 2025, Visionary Holdings Inc.  successfully convened the First Meeting of the Fourth Board of Directors. In strict compliance with the Business Corporations Act , Securities Exchange Act of 1934 , NASDAQ Listing Rules, and the relevant provisions of the Company's Bylaws, the meeting was conducted with legitimate convening procedures, qualified participants, and rigorous voting rules. All directors attended the meeting and unanimously adopted all core proposals, with the resolutions being legally valid, laying a solid institutional foundation for the Company's stable operations in the next phase.As a significant milestone in the Company's development, the meeting completed key deployments for optimizing the governance structure and forming the core team, establishing a professional and efficient collaborative governance ecosystem:","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSYW.SI","BK4204","GB00BDT5M118.USD","USA","QID","USJW.SI","LU1992135399.USD","BK4585","BK4120",".IXIC","COO","CEO","QLD","BK4198","CFO","LU2272731600.USD","LU1992135472.HKD","LU2272731782.SGD","TISI","TQQQ","LU2211815571.USD","MNQmain","PSQ","SQQQ","NVIW.SI","USAW.SI","BK4588","GV"],"gpt_icon":1},{"id":"2580734116","title":"K Wave Media Appoints Yong Fang as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2580734116","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580734116?lang=en_us&edition=fundamental","pubTime":"2025-11-04 21:12","pubTimestamp":1762261920,"startTime":"0","endTime":"0","summary":"NEW YORK and SEOUL, Nov.  04, 2025  (GLOBE NEWSWIRE) -- K Wave Media (Nasdaq: KWM), a Korean cultural innovation and digital asset company, today announced the appointment of Yong (Howard) Fang as its","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/04/3180318/0/en/K-Wave-Media-Appoints-Yong-Fang-as-Chief-Financial-Officer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4120","CFO","RTO","LU0205194284.USD","TTTN","IPO","LU0240877869.USD","LU0205193047.USD","IE0009354923.USD","LU0240878834.USD"],"gpt_icon":0},{"id":"2579273177","title":"Press Release: Bank of the James Announces CFO--CIO Transition and Appointment of New Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2579273177","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579273177?lang=en_us&edition=fundamental","pubTime":"2025-10-31 04:30","pubTimestamp":1761856200,"startTime":"0","endTime":"0","summary":"LYNCHBURG, Va., Oct. 30, 2025  -- Bank of the James Financial Group, Inc.  , the parent company of Bank of the James , a full-service commercial and retail bank, and Pettyjohn, Wood & White, Inc. , an SEC-registered investment advisor, today announced changes to the Bank's executive leadership to improve oversight and better coordinate financial and investment approaches.-- J. Todd Scruggs, currently serving as Chief Financial Officer, will. transition to the new role of Chief Investment Officer .-- Eric J. Sorenson, Jr., who has served as General Counsel for more than. three years and has advised the Bank and the Company on regulatory, legal,and financial matters for over 25 years, will be appointed as Chief. Mr. Sorenson has served as Executive Vice President - General Counsel of the Bank since 2022, guiding the Ban","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CIO","CFO","BK4211","BOTJ","BK4194","BK4223"],"gpt_icon":0},{"id":"1115399854","title":"Fiserv Cuts Annual Profit Forecast, Shares Plunge 27%","url":"https://stock-news.laohu8.com/highlight/detail?id=1115399854","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115399854?lang=en_us&edition=fundamental","pubTime":"2025-10-29 20:03","pubTimestamp":1761739426,"startTime":"0","endTime":"0","summary":"Focus: Q3 2025 U.S. Earnings Season   Payment services provider Fiserv slashed its annual profit forecast for the second consecutive quarter on Wednesday and announced a sweeping leadership overhaul...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"433e4251d16de9467ab458a4dee34040","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CEO","CFO"],"gpt_icon":0},{"id":"2579977634","title":"Lifecore Biomedical Selected as New Commercial Manufacturing Partner by Leading Global Pharmaceutical Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2579977634","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579977634?lang=en_us&edition=fundamental","pubTime":"2025-10-29 19:00","pubTimestamp":1761735600,"startTime":"0","endTime":"0","summary":"Lifecore to Execute Commercial Site Transfer and Become New Supplier of Choice for Leading Commercial Injectable Pharmaceutical Product Represents Second Agreement Signed with Same Major Multinational","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/29/3176253/23089/en/Lifecore-Biomedical-Selected-as-New-Commercial-Manufacturing-Partner-by-Leading-Global-Pharmaceutical-Company.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4212","CDMO","BK4121","LFCR","CFO","BK4139"],"gpt_icon":0},{"id":"2578959887","title":"Lifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2578959887","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578959887?lang=en_us&edition=fundamental","pubTime":"2025-10-28 19:00","pubTimestamp":1761649200,"startTime":"0","endTime":"0","summary":"CHASKA, Minn. and TORRANCE, Calif., Oct.  28, 2025  (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ:LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“C","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/28/3175225/23089/en/Lifecore-and-PolyPeptide-Announce-Collaboration-Intended-to-Offer-End-to-End-Peptide-Manufacturing-Solution-for-U-S-Market.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4121","CDMO","CFO","LFCR","BK4212"],"gpt_icon":0},{"id":"2578557605","title":"Elon Musk Loses Another Top Executive As X's Ad Chief Reportedly Quits","url":"https://stock-news.laohu8.com/highlight/detail?id=2578557605","media":"Benzinga_recent_news","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578557605?lang=en_us&edition=fundamental","pubTime":"2025-10-25 15:00","pubTimestamp":1761375600,"startTime":"0","endTime":"0","summary":"John Nitti, who served as global head of revenue operations and advertising innovation at X, has left the social media company after just 10 months in the role, according to a report by the Financial Times on Friday.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/10/25/Twitter-Logo-After-Renaming-The-Company-.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/10/25/Twitter-Logo-After-Renaming-The-Company-.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/tech/25/10/48421431/elon-musk-loses-another-top-executive-as-xs-ad-chief-reportedly-quits","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/tech/25/10/48421431/elon-musk-loses-another-top-executive-as-xs-ad-chief-reportedly-quits","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["LU0444973449.USD","LU2028103732.USD","LU1804176565.USD","LU0985489474.SGD","SHEL","LU1668664300.SGD","IE00B19Z3581.USD","LU0130518102.USD","LU0175139822.USD","LU1221951046.USD","TSYW.SI","USJW.SI","LU2471134879.HKD","BK4527","LU1852331112.SGD","LU0061474705.USD","LU1037948897.HKD","PINS","LU0494093205.USD","LU2125154778.USD","LU1674673428.USD","LU1934455194.USD","SG9999018857.SGD","CFO","UFO","SG9999002224.SGD","BK4127","LU2168564149.EUR","BK4579","BK4551","SG9999014898.SGD","DXYZ","LU1162221912.USD","LU2098885051.SGD","BK4555","LU1280957306.USD","LU2471134952.CNY","IE00BN29S564.USD","LU1989764748.USD","LU0648000940.SGD","LU1629891620.HKD","LU1363072403.SGD","LU1989764664.SGD","LU0208291251.USD","BK4574","LU2552382215.SGD"],"gpt_icon":1},{"id":"2576543071","title":"Avacta Therapeutics Presents Compelling Phase 1a Data for Faridoxorubicin and the pre|CISION® Platform at the European Society of Medical Oncology Annual Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2576543071","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576543071?lang=en_us&edition=fundamental","pubTime":"2025-10-19 22:00","pubTimestamp":1760882400,"startTime":"0","endTime":"0","summary":"Median progression free survival (PFS) has not been reached in the cohort of patients with salivary gland cancer with PFS follow up suggesting a more than doubling of the benchmark PFS and a disease c","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/19/3169020/0/en/Avacta-Therapeutics-Presents-Compelling-Phase-1a-Data-for-Faridoxorubicin-and-the-pre-CISION-Platform-at-the-European-Society-of-Medical-Oncology-Annual-Congress.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ECHO","IE00BYQNZ168.SGD","BK4567","BK4535","LU1093756168.USD","BK4108","ADT","BK4539","BK4571","TME","BK4131","BK4563","BK4121","01698","BK4548","LU1721428933.USD","BK4139","PFS","CEO","LU2039709279.SGD","LU1093756325.SGD","BK4526","IE00B12V2V27.USD","LU0359201612.USD","LU2413666426.HKD","IE00BYQQ9H92.USD","BK4552","BK4213","LENZ","LU0456842615.SGD","AR","LU2211817866.USD","SG9999011746.SGD","CFO","BK4165","BK4585","BK4588","BK4531","LU1023057109.AUD","BK4195","MTD","LU0347712357.USD","BK4509","LU0359202008.SGD","LU2413666699.HKD","BK4192","BK4007","IE00BFXG0V08.USD","BK4211","BK4565"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":76,"code":"91000000","status":"200"}]}}